✦ LIBER ✦

Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study

✍ Scribed by Andrzej J. Jakubowiak; Paul G. Richardson; Todd Zimmerman; Melissa Alsina; Jonathan L. Kaufman; Malathi Kandarpa; Stephanie Kraftson; Charles W. Ross; Colleen Harvey; Teru Hideshima; Peter Sportelli; Enrique Poradosu; Lesa Gardner; Kathy Giusti; Kenneth C. Anderson

Book ID: 114714749
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 248 KB
Volume: 158
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09173.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A347 Phase I Trial of Perifosine, Lenali

A347 Phase I Trial of Perifosine, Lenalidomide, and Dexamethasone in Relapsed or Refractory Myeloma

✍ Jakubowiak, AJ; Hideshima, T; Sportelli, P; Gardner, L; Giusti, K; Richardson, P 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Expanded safety experience with lenalido

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma

✍ Christine Chen; Donna E. Reece; David Siegel; Ruben Niesvizky; Ralph V. Boccia; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

The efficacy and safety of lenalidomide

The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

✍ Meletios Dimopoulos; Adrian Alegre; Edward A. Stadtmauer; Hartmut Goldschmidt; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

The addition of cyclophosphamide to lena

The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study

✍ Stephen A. Schey; Gareth J. Morgan; Karthik Ramasamy; Beth Hazel; Dariusz Ladon; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Atacicept in relapsed/refractory multipl

Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study

✍ Rossi, J-F; Moreaux, J; Hose, D; Requirand, G; Rose, M; Rouillé, V; Nestorov, I; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 287 KB

A phase I safety study of enzastaurin pl

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma

✍ Irene M. Ghobrial; Nikhil C. Munshi; Brianna N. Harris; Peipei Shi; Nichole M. P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views